Morgan Stanley lowered the firm’s price target on Houlihan Lokey (HLI) to $156 from $190 and keeps an Overweight rating on the shares. Recent trade developments raise recession risk and the firm expects the M&A pipeline to be impacted by deteriorating market conditions and prolonged uncertainty for CEOs looking to do deals, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLI:
